Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV

Meier, Werner; du Bois, Andreas; Rau, Joern; Gropp-Meier, Martina; Baumann, Klaus; Huober, Jens; Wollschlaeger, Kerstin; Kreienberg, Rolf; Canzler, Ulrich; Schmalfeldt, Barbara; Wimberger, Pauline; Richter, Barbara; Schroeder, Willibald; Belau, Antje; Staehle, Anne; Burges, Alexander; Sehouli, Jalid

dc.contributor.author	Huober, Jens	de_DE
dc.date.accessioned	2014-03-24T14:30:18Z
dc.date.available	2014-03-24T14:30:18Z
dc.date.issued	2012	de_DE
dc.identifier.issn	0090-8258	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/50392
dc.language.iso	en	en
dc.publisher	Academic Press Inc Elsevier Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ygyno.2012.04.050	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01686	de_DE
utue.publikation.seiten	236-240	de_DE
utue.personen.roh	Meier, Werner	de_DE
utue.personen.roh	du Bois, Andreas	de_DE
utue.personen.roh	Rau, Joern	de_DE
utue.personen.roh	Gropp-Meier, Martina	de_DE
utue.personen.roh	Baumann, Klaus	de_DE
utue.personen.roh	Huober, Jens	de_DE
utue.personen.roh	Wollschlaeger, Kerstin	de_DE
utue.personen.roh	Kreienberg, Rolf	de_DE
utue.personen.roh	Canzler, Ulrich	de_DE
utue.personen.roh	Schmalfeldt, Barbara	de_DE
utue.personen.roh	Wimberger, Pauline	de_DE
utue.personen.roh	Richter, Barbara	de_DE
utue.personen.roh	Schroeder, Willibald	de_DE
utue.personen.roh	Belau, Antje	de_DE
utue.personen.roh	Staehle, Anne	de_DE
utue.personen.roh	Burges, Alexander	de_DE
utue.personen.roh	Sehouli, Jalid	de_DE
dcterms.isPartOf.ZSTitelID	Gynecologic Oncology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	126	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE